Label: VARDENAFIL tablet, orally disintegrating
Patients with a "crowed" optic disc may also be at an increased risk of NAION.
| Brand Name | Manufacturer | Formulation Type | Price Range | Notes |
|---|---|---|---|---|
| Levitra | Bayer | Tablet | Moderate | Widely used |
| Staxyn | Bayer | Orally disintegrating tablet | Similar price | Alternative formulation |
| Generic Vendors | Multiple | Tablet | Lower | Cost-effective option |
Sudden hearing loss - patients should stop treatment and seek medical attention in the event of sudden decrease or loss in hearing Alpha-blockers - caution is advised when PDE5 inhibitors are co-administered with alpha-blockers.
- Vardenafil 10 mg is one of several ED treatment options.
- It is generally well-tolerated when used properly.
- Take care to follow your healthcare provider’s instructions.
- Possible interactions with antihypertensive drugs exist.
- Do not drive or operate machinery if feeling dizzy.
- Keep a record of any side effects experienced.
- The medication is not a cure for erectile dysfunction.
- Combining vardenafil with other ED drugs is dangerous.
- Take the tablet with a full glass of water.
- Consult your doctor for dose adjustments if needed.
In some patients, concomitant use of these two drug classes can lower blood pressure significantly leading to symptomatic hypotension (for example, fainting) QT prolongation - patients with congenital QT syndrome or taking class IA or III antiarrhythmics should avoid using Vardenafil Other erectile dysfunction therapies - the safety and efficacy of vardenafil used in combination with other treatments for ED have not been studied.
- Side effects can include headache, flushing, or stomach upset.
- Serious side effects are rare but require immediate medical attention.
- Vardenafil may cause changes in color vision.
- Use caution if using other medication for blood pressure.
- The medication helps improve erectile function temporarily.
- Do not share tablets with others.
- Follow storage instructions to maintain efficacy.
- Report any allergic reactions promptly.
- The drug should be used only under medical supervision.
- Used responsibly, vardenafil can improve quality of life.
Signs and symptoms may include reversible back pain/myalgia and/or "abnormal vision." Standard supportive measures should be taken as required. Renal dialysis is not expected to accelerate clearance as vardenafil is highly bound to plasma proteins and not significantly eliminated in the urine. Pregnancy: Pregnancy Category B; not indicated for use in women.
What happens if I overdose?
It competes with tadalafil (Cialis) and sildenafil (Viagra), which have similar efficacy but differ in duration and side effect profile. Commercially, the ED market is expanding due to increasing prevalence related to aging populations and rising awareness. The global aging demographic is expected to increase ED prevalence from 10% to 30% in men aged 40–70. Market growth is driven by increased focus on sexual health, over-the-counter availability in some regions, and newer formulations improving patient adherence. The popularity of combination therapies and the rise of telemedicine further influence demand dynamics.
Pregnancy Categories
Projection estimates forecast the ED market reaching over $6.5 billion globally by 2028, with vardenafil contributing approximately 15–20% of this value. Compound annual growth rate (CAGR) calculations suggest a 5–6% growth from 2023 to 2028, primarily propelled by: Expansion into emerging markets (Asia-Pacific, Latin America) Increased acceptance of generics, reducing patient costs Rise in over-the-counter product availability Technological innovations in formulation (e.g., fast-dissolving tablets) Regional variations could influence market share: North America is expected to be the dominant segment, but Asia-Pacific will witness the fastest growth, with a CAGR near 8%, due to higher prevalence and lower treatment access costs. Manufacturing costs for vardenafil have declined due to economies of scale and global production. Generic production costs are estimated at $0.10–$0.15 per pill, compared to branded formulations at $1.00–$2.00, creating profit margins of 85–90% for generics. Regulatory harmonization reduces approval timelines and cost, fostering quicker market entry. Nursing Mothers: Not indicated for use in women.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Original | 100mg | 22 + 2 Pills | 120.71€ 114.96€ | |
| Viagra Generic | 150mg | 90 + 6 Pills | 147.18€ 140.17€ | |
| Viagra Generic | 150mg | 20 Pills | 55.02€ 52.40€ | |
| Viagra Professional | 100mg | 270 + 6 Pills | 456.97€ 435.21€ | |
| Cialis Generic | 40mg | 20 Pills | 59.47€ 56.64€ | |
| Viagra Generic | 100mg | 360 + 10 Pills | 330.21€ 314.49€ | |
| Viagra Soft Tabs | 100mg | 60 + 6 Pills | 152.94€ 145.66€ | |
| Kamagra Polo | 100 mg | 120 + 6 Pills | 327.15€ 311.57€ | |
| Levitra Soft Tabs | 20mg | 10 Pills | 52.27€ 49.78€ | |
| Cialis Generic | 60mg | 120 + 8 Pills | 240.18€ 228.74€ | |
| Cialis Professional | 40mg | 60 + 2 Pills | 262.32€ 249.83€ | |
| Cialis Black | 80mg | 90 + 6 Pills | 207.88€ 197.98€ | |
| Cialis Professional | 40mg | 10 Pills | 65.09€ 61.99€ |
Renal Impairment: Do not use in patients on renal dialysis; no dosage adjustment necessary in patients with ClCr 30-80 mL/min.
Before Using
The segment including vardenafil accounts for roughly 20% of this market, with an estimated revenue of $800 million in 2022. Key manufacturers include Bayer, Teva Pharmaceuticals, and Sun Pharma. The generic segment's share increased from 15% in 2015 to over 50% by 2022, driven by patent expirations and regional generics proliferation. Bayer's patent for Levitra expired in 2018, allowing generic manufacturers to enter multiple markets. This reduced prices by an estimated 40–60%, impacting branded sales.
Mechanism of Action
The expiration facilitated increased accessibility and expanded the patient base, especially in emerging markets. In the US, the final patent expiration occurred in 2020. The European patent expired in 2017, leading to a surge in generic imports. Patent cliffs across major markets significantly shifted revenue streams, transitioning from branded dominance to a generics-focused market. The drug's pharmacology remains stable with a half-life of 4–5 hours, allowing for flexible dosing. Hepatic Impairment: Do not use in patients with severe impairment (Child-Pugh C); dosage adjustment is necessary in patients with moderate impairment.
Dose Adjustments
Are there ongoing research efforts for new formulations? Limited, primarily from generic manufacturers focusing on fast-dissolving forms or combination therapies; innovation is more incremental than breakthrough. Country-specific approval processes, patent laws, and price regulations influence how quickly new generic or branded formulations enter markets. Erectile Dysfunction Drugs Market by Product, Distribution Channel, and Region: Global Forecast to 2028. [5] U.S. Pediatric Patients: Not indicated for use in pediatric patients; safety and efficacy have not been established in this population. Geriatric Patients: No differences in safety and effectiveness noted between elderly (≥65 years of age) and younger patients.
What are the future revenue projections and growth drivers?
Competition from new drugs or alternative therapies. Regulatory changes increasing approval or manufacturing costs. Pricing pressures due to government-mandated price reductions. Operational risk stems from supply chain disruptions and geopolitical issues impacting manufacturing or distribution. Patent expirations significantly increased generic entry, reducing prices and expanding access.
What is vardenafil, and what is it used for?
Revenue growth predictions remain positive but are moderated by regulatory policies and pricing pressures. Emerging markets will drive growth, with regional variations influencing market share. Innovation in formulation remains limited but could alter competitive dynamics. Overall, the market for vardenafil hydrochloride continues to evolve with rising demand for ED treatments and increased generic availability. How does vardenafil compare to buy cenforce pills other PDE5 inhibitors? However, due to increased vardenafil concentrations in the elderly, a starting dose of 5 mg should be considered in the elderly. Vardenafil may add to the blood pressure lowering effects of antihypertensive agents. Effects on Blood Pressure and Heart Rate when Combined with Nitrates: A study was conducted in which the blood pressure and heart rate response to 0.4 mg nitroglycerin (NTG) sublingually was evaluated in 18 healthy subjects following pretreatment with vardenafil 20 mg at various times before NTG administration.
Vardenafil dosing information
Countries with streamlined approval processes, such as India and Brasil, enable faster revenue realization. Conversely, stringent regulations in the US and EU can delay launches, impacting short-term revenue but fostering long-term stability. Pricing policies vary, with government-mandated price caps in several markets influencing profit margins. For instance, India enforces prices 30–40% lower than international reference prices, reducing profit potential but increasing volume sales. Generic vardenafil dominates due to patent expiry, with leading players capturing over 60% of the accessible market: Teva Pharmaceuticals: Largest global producer with extensive distribution channels.
Medications & Supplements
Sun Pharma: Focused on Asian markets, rapidly expanding in Latin America. Mylan: Active in the US and Europe with competitive pricing. Brand dominance persists in some regions, especially where patent protections remain valid or where consumer preference favors branded formulations. Innovation in delivery mechanisms (e.g., fast-dissolving tabs, new formulations) is limited but ongoing, primarily driven by generic manufacturers. Patent litigation or patent extensions delaying generic entry. Additional blood pressure and heart rate changes were not detected when vardenafil 20 mg was dosed 24 hours before NTG. Because the disease state of patients requiring nitrate therapy is anticipated to increase the likelihood of hypotension, the use of vardenafil by patients on nitrate therapy or on nitric oxide donors is contraindicated. Blood Pressure Effects in Patients on Stable Alpha-Blocker Treatment: Three clinical pharmacology studies were conducted in patients with benign prostatic hyperplasia (BPH) on stable-dose alpha-blocker treatment, consisting of alfuzosin, tamsulosin or terazosin.
Key Financial Metrics and Trends Summary
Food and Drug Administration (FDA). 10 mg as needed, 60 minutes prior to sexual activity Increase to 20 mg or decrease to 5 mg based on efficacy/tolerability For patients taking potent or moderate inhibitors of CYP3A4, dose adjustment is as follows: Ritonavir: no more than 2.5 mg in a 72-hour period Indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, clarithromycin: no more than 2.5 mg in a 24-hour period Ketoconazole 200 mg daily, itraconazole 200 mg daily, erythromycin: no more than 5 mg in a 24-hour period. Cardiovascular effects - patients should not use Vardenafil if sex is inadvisable due to cardiovascular status. Risk of priapism - in the event that an erection lasts more than 4 hours, the patient should seek immediate medical assistance Effects on the eye - patients should stop treatment and seek medical attention in the event of sudden loss of vision in one or both eyes, which could be sign of nonarteritic anterior ischemic optic neuropathy (NAION). Use with caution, and only when the anticipated benefits outweigh the risks, in patients with a history of NAION. The design was a randomized, double blind, cross-over study with four treatments: vardenafil 5 mg or placebo administered simultaneously with the alpha-blocker and vardenafil 5 mg or placebo administered 6 hours after the alpha- blocker.
| Parameter | Result | Notes |
|---|---|---|
| Absorption Time | 30-60 minutes | Time to peak plasma concentration (Tmax) |
| Bioavailability | ~15% | Percentage of dose reaching systemic circulation |
| Half-life | 4-5 hours | Duration of effect |
| Metabolism | Liver (CYP3A4 enzyme) | Mainly via hepatic pathways |
| Excretion | Feces (~60%), Urine (~20%) | Primary routes |
Study 2: This study was designed to evaluate the effect of 10 mg vardenafil (stage 1) and 20 mg vardenafil (stage 2) compared to placebo, when administered to a single cohort of BPH patients (n=23) on stable therapy with tamsulosin 0.4 mg or 0.8 mg daily for at least four weeks.
8.5 Geriatric Use
Vardenafil has a similar efficacy profile to sildenafil and tadalafil but features a quicker onset of action. Its half-life of 4–5 hours suits flexible dosing. Pricing is affected by patent status, regional regulation, competition, and whether the drug is branded or generic. Which markets offer the highest growth potential? Emerging markets such as India, China, and Latin America present the highest growth potential due to increasing prevalence and affordability factors.